R1-N AND PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF, WHEREIN R1 IS A HYDROCARBON RADICAL OF 1 TO 6 C-ATOMS; EACH OF R2 AND R3 IS C1-C5 ALKYL, C2-C5 ALKENYL OR C1-C9 ARALKYL; OR WHERE
-N(-R2)-R3
CAN BE A 5- TO 7-MEMBERED HETEROCYCLIC RING, ARE ANALGESICS OF LOW TOXICITY IN MAMMALS.
Abstract:
The present invention relates to a process for producing cephalosporin derivatives of the general formula:
WHEREIN R is hydrogen or an acyl group, which comprises treating a compound of the general formula:
WHEREIN R is as defined above, with a divalent chromium compound such as chromous acetate or chromous sulfate. According to the method of the present invention cephalosporin derivatives can be obtained in a high purity and high yield without the use of expensive large amounts of metal catalysts. Cephalosporin derivatives are known to have good adsorption and/or distribution in the living body and some of the compounds derived according to the present invention have excellent value in the treatment of various bacterial infections.
Abstract:
WHEREIN R is hydrogen or an acyl group and X is hydrogen or a halogen, which have a broad antimicrobial spectrum, including Pr. Morganii. Examples thereof include 7- (2''-thienylacetamido)-3(2''''-pyridylthiomethyl)-3-cephem-4-carboxylic acid 1''''-oxide, 7(phenylacetamido)-3-(2''-pyridylthiomethyl)-3-cephem-4-carboxylic acid 1''-oxide, 7-(phenoxyacetamido)-3-2''-pyridylthiomethyl)-3cephem-4-carboxylic acid 1''-oxide and 7-(5''-amino-5''carboxyvalerylamido)-3-(2''''-pyridylthiomethyl)-3-cephem -4carboxylic acid 1''''-oxide.
Abstract:
New cephalosporin derivatives of the formula,
WHEREIN R represents the same or different substituent selected from halogen atom, nitro group, lower alkyl group, amino group or carboxylic group, n is an integer from 0 to 3 and X represents hydrogen or halogen atom. These compounds are remarkably effective for inhibiting the growth of a broad range of microorganisms including Proteus morganii and Mycobacterium tuberculosis. Examples thereof include 7-(1''-pyrazolylacetamido)3-(2''''-pyridylthiomethyl)-3-cephem-4-carboxylic acid 1''''-oxide, 7-(4''-nitro-1''-pyrazolylacetamido)-3-(2''''-pyridylthiomethyl)-3cephem-4 -carboxylic acid 1''''-oxide, 7-(4''-chloro-1''pyrazolylacetamido)-3-(2''''-pyridylthiomethyl)-3-cephem -4carboxylic acid 1''''-oxide, 7-(3'',5''-dimethyl-1''pyrazolylacetamido)-3-(2''''-pyridylthiomethyl)-3-cephem -4carboxylic acid 1''''-oxide and 7-(1-pyrazolylacetamido)-3-(4''chloro-2''-pyridylthiomethyl)-3-cephem-4 -carboxylic acid 1''oxide.
AND PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF WHEREIN EACH OF R1 AND R2 IS METHYL OR ALLYL OR R1 AND R2 TAKEN TOGETHER WITH THE ADJACENT NITROGEN ATOM ARE MORPHOLINO OR PIPERIDINO AND EACH OF R3 AND R4 IS ALKYL OF ONE TO FIVE CARBON ATOMS, ALLYL OR BENZYL OR R3 AND R4 TAKEN TOGETHER WITH THE ADJACENT NITROGEN ATOM ARE MORPHOLINO, PIPERIDINO, 4-BENZYLPIPERAZINO, 4-P-CHLORPHENYLPHENYLPIPERAZINE, HEXAMETHYLENIMINO, 4-METHYLPIPERAZINO, 4FORMYLPIPERAZINO, PIPECOLINO AND PYRROLIDINO ARE PROVIDED. THE NOVEL COMPOUNDS ARE PRODUCED BY A NOVEL PROCESS WHICH COMPRISES REACTING A COMPOUND OF THE FORMULA:
3-(R1-N(-R2)-),5-(O-)-1,2,3-OXADIAZOLE
WHEREIN R1 AND R2 HAVE THE SAME MEANING AS DEFINED ABOVE IS REACTED WITH FORMALDEHYDE AND A SECONDARY AMINE OF THE FORMULA
R3-NH-R4
WHEREIN R3 AND R4 HAVE THE SAME MEANING AS DEFINED ABOVE. SYDNONE DERIVATIVES OF THE FORMULA
AND PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF, WHEREIN EACH OF R1, R2, R3 AND R4 IS C1-C5 ALKYL, C2-C5 ALKENYL OR C7-C9 ARALKYL, OR WHERE 3-(R1-N(-R2)-),5-(O-)-1,2,3-OXADIAZOLE
IS A 5- TO 7-MEMBERED HETEROCYCLIC RING, ARE ANALGESICS OF LOW TOXICITY IN MAMMALES. THEY ARE PREPARED BY REACTING THE APPROPRIATE COMPOUND OF THE FORMULA
Abstract:
Novel compounds of the general formula NR111R112.N(NO).CHR3.CN wherein R3 represents a hydrogen atom or a C1- 5 alkyl group and each of R111 and R112 represent a C1- 5 alkyl or a C2- 5 alkenyl group, or R111 and R112, together with the nitrogen atom to which they are attached, represent a morpholino or pipecolino radical or a radical of the formula I, wherein n represents 4, 5 or 6, or a radical of the formula II, wherein R1 represents a C1- 5 alkyl radical or a radical of the formula are prepared by treating an aminoalkylhydrazine of the formula NR11R12.NH.CHR3.CN, R11 and R12 having the same meanings as R111 and R112 except that when R111 and R112, together with the nitrogen atom, represent a radical of the formula I, R1 represents a C1- 5 alkyl radical or a radical of the formula (a) with an alkali metal or ammonium nitrite, (b) with nitrous fumes, (c) with nitrosyl chloride in the presence of an alkali metal carboxylate or (d) with an alkyl nitrite or by treating with a nitrosating agent the aminoalkyl-hydrazine of the above formula obtained by reacting a hydrazine of the formula NR11R12.NH2 with an aldehyde of the formula R3CHO and an alkali metal or ammonium cyanide